Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
An IABP may improve survival chances in advanced cardiogenic shock, but results are mixed and depend on the patient's specific condition.
Yes, observational studies suggest pulmonary artery catheter use is linked to lower in-hospital mortality in cardiogenic shock, but randomized trials are lacking.
Immediate surgery does not improve outcomes for all STEMI patients with multivessel disease, and it may increase risks for those with heart failure.
For STEMI with multivessel disease, immediate and staged revascularization show similar outcomes overall, but staged may be safer in patients with heart failure or cardiogenic…
For most patients with STEMI and multivessel disease, immediate and staged revascularization have similar risks of death or heart attack, but staged may reduce the need for…
Yes, a post-hoc analysis of the AFIRE trial found that in patients with atrial fibrillation and stable CAD, lower baseline systolic blood pressure (≤126 mmHg) was linked to…
Using FFR guidance to decide on stenting reduces the need for repeat heart surgery in patients with multivessel coronary artery disease.
Adding VOM ethanol infusion to standard catheter ablation improves the chance of keeping a normal heart rhythm in persistent atrial fibrillation.
Adding rotational activity ablation to standard procedures increases the rate of sinus rhythm maintenance to 91.5% in persistent AF patients, compared to lower rates with…
Yes, the benefits of mRNA COVID-19 vaccines in preventing severe disease far outweigh the rare, usually mild risk of myocarditis, especially in young males.
Pediatric heart failure from myocarditis or MIS-C is managed by identifying immune triggers, using multimodal tests to distinguish active inflammation from chronic damage, and…
Continuous heart rate monitoring helps detect early signs of illness in premature infants with necrotizing enterocolitis, allowing for timely intervention that can improve…
Yes, early surgery significantly reduces long-term death risk in asymptomatic very severe aortic stenosis, with a 90% lower risk of cardiovascular death over 10 years.
Yes, multiple large studies show that RAS inhibitors after TAVR are associated with lower all-cause and cardiovascular mortality.
Yes, sex may influence cardiovascular death risk after TIA, but evidence is mixed; some studies show no significant difference, while others suggest women may have lower risk.
Yes, machine-learning models can predict coronary artery lesions in children with Kawasaki disease, with some achieving high accuracy (AUC up to 0.95).
No, adding prednisolone to standard treatment did not significantly reduce coronary artery lesions at 1 month in newly diagnosed Kawasaki disease patients, according to a large…
Routine lab indicators like C-reactive protein and erythrocyte sedimentation rate help predict coronary artery lesions in children with Kawasaki disease.
Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not…
Yes, Xarelto (rivaroxaban) is FDA-approved to reduce stroke risk in nonvalvular atrial fibrillation and to treat deep vein thrombosis, making it effective for patients with both…
Yes, the apical sparing ratio (ASR) can help detect cardiac amyloidosis, but it is not perfect—it has moderate accuracy and should be used alongside other tests.
Cardiac MRI with contrast and bone scintigraphy are the best tests for distinguishing cardiac amyloidosis from other heart issues, with echocardiography as a useful first…
A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.
Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.